Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2008
04/10/2008WO2008040764A1 Substituted 4-phenyl piperidines for use as renin inhibitors
04/10/2008WO2008040097A1 Furanone compounds and lactam analogues thereof
04/10/2008WO2008014497A3 Aldh-2 inhibitors in the treatment of addiction
04/10/2008WO2007136875A3 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
04/10/2008WO2007120824A3 Processes for the synthesis of azetidinone
04/10/2008WO2007110868A3 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
04/10/2008US20080086011 Processes for the preparation of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino[sulfonyl}-2-thiophenecarboxamide
04/10/2008US20080086003 1-[4-amino-3,5-dibromo-N-[[4-(2,3,4,5-tetrahydro-2(1H)-oxo-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]-D-phenylalanyl]-4-(1-piperidinyl)-piperidine-p-toluenesulphonate or other inorganic organic salts; calcitonin gene related peptide-antagonist; useful for treating headache and migraine
04/10/2008US20080085899 Tetrahydrothiopyrano pyrazole cannabinoid modulators
04/10/2008US20080085896 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
04/10/2008US20080085895 Substituted Chiral Fused [1,2]Imidazo[4,5-C] Ring Compounds
04/10/2008US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors
04/10/2008US20080085893 N-Hydroxy (2S)-2-hydroxy phenyl or heteroaryl sulfonamide derivatives; for example, N-Hydroxy (2S)-2-hydroxy-3-{N-[4-(4- chlorophenoxy)phenyl], N- methanesulfonylamino}propionamide; for treating disorders related to matrix metalloproteases, particularly useful for treating strokes;
04/10/2008US20080085886 Anticancer and/or antiinflammatory activity, MEK (MAP kinase kinase) inhibitors; for example, 3-(2-Fluoro-4-iodo-phenylamino)-furo[3,2-c]pyridine-2-carboxylic acid ((R)-2,3-dihydroxy-propoxy)-amide
04/10/2008CA2665083A1 Mglur5 modulators
04/10/2008CA2664842A1 Arginine derivatives with np-i antagonistic activity
04/10/2008CA2642455A1 Substituted 4-phenyl piperidines for use as renin inhibitors
04/09/2008EP1908762A2 Organic compounds
04/09/2008EP1908761A1 Organic compounds
04/09/2008EP1908752A1 Novel 2-quinolone derivative
04/09/2008EP1907385A2 Compounds
04/09/2008EP1907384A2 Gpcr agonists
04/09/2008EP1907383A1 Gpcr agonists
04/09/2008EP1907382A1 Nitrocatechol derivatives as comt inhibitors
04/09/2008EP1907381A1 Antidiabetic oxazolidinediones and thiazolidinediones
04/09/2008EP1907372A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists
04/09/2008EP1907362A1 Amide derivatives as kinase inhibitors
04/09/2008EP1907359A2 3,5-substituted piperidine derivatives effective on renin-related disorders
04/09/2008EP1906964A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists
04/09/2008EP1594867B1 Phenylacetamides and their use as glucokinase modulators
04/09/2008CN101160308A Methods of treating cancer and related methods
04/09/2008CN101160307A Benzoxazole carboxamides for treating cinv and ibs-d
04/09/2008CN101160303A 1-(2H)-isoquinolone derivative
04/09/2008CN101160301A Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers
04/09/2008CN101160295A 3,4-dihydro-benzo[e][1,3]oxazin-2-ones
04/09/2008CN101160293A Azole derivatives in the form of lipase and phospholipase inhibitors
04/09/2008CN101160287A 吡啶基非芳香族含氮杂环-1-羧酸酯衍生物 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative
04/09/2008CN100379727C Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation
04/09/2008CN100379415C Hetero biaryl derivatives as matrix metalloproteinase inhibitors
04/08/2008US7355054 Indole derivatives
04/08/2008US7355042 Sleep disorders; side effect reduction
04/08/2008US7354945 Compounds as enzyme inhibitors, cosmetics, antitumor agents and food supplements
04/08/2008US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
04/08/2008US7354938 4[2(2,4chlorophenyl)pyrazol]-phenyl-cyclopropan; 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor; antidiabrtic agent, obesity, insulin resistance; improved physicochemical (stability) and biological (activity to inhibit HSD1, specificity, bioavailability, metabolism)
04/08/2008US7354920 Aryl and heteroaryl morpholine derivatives
04/08/2008US7354919 Isoxazole compositions useful as inhibitors of ERK
04/08/2008US7354918 cerebral oxygenators and vasoregulators; antidepressant, cognition activator; sleep disorders; enantiomer mixture separated by HPLC; classical antidepressants resistance
04/08/2008CA2188924C Arylpiperidine and arylpiperazine derivatives and drugs containing the same
04/08/2008CA2187541C Benzoxazepine derivatives, salts thereof, and drugs containing the same
04/03/2008WO2008039023A1 Heteroaryl-pyrazole derivatives as cannabinoid cb1 receptor antagonists
04/03/2008WO2008038251A2 3-aza-bicyclo[3.1.0]hexane derivatives
04/03/2008WO2008038010A1 Pyrazine derivatives and their use in therapy
04/03/2008WO2008037789A1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives
04/03/2008WO2008037784A1 Quinolinone derivatives
04/03/2008WO2008037381A1 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals
04/03/2008WO2008019072A3 Polymorphs of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)-amino]sulfonyl}-2-thiophene-carboxamide
04/03/2008WO2008018639A3 Glycine transporter inhibitor
04/03/2008WO2008014291A3 Compounds and compositions as hedgehog signaling pathway modulators
04/03/2008WO2007145349A3 Substituted pyrrole derivatives
04/03/2008WO2007139413A3 Polymorphs of (r) -5- (2-aminoethyl) -1- (6, 8-difluorochroman-3-yl) -1,3- dihydroimidazole-thione hydrochloride
04/03/2008WO2007130429A3 Histone deacetylase and tubulin deacetylase inhibitors
04/03/2008WO2007086001A3 Novel pyridine derivatives
04/03/2008WO2007070359A3 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
04/03/2008US20080081907 5-HT5A serotonin receptor activity; such as (5-Methyl-furan-2-ylmethyl)-(5-phenoxymethyl-quinolin-2-yl)-amine; anxiety, depression, sleep disorders, schizophrenia
04/03/2008US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases
04/03/2008US20080081815 Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
04/03/2008US20080081814 Carbonyl Compounds Which Can be Used as Inhibitors of Coagulation Factor Xa
04/03/2008US20080081813 Lipid Lowering Biphenylcarboxamides
04/03/2008US20080081811 5-[2-(cyclohexyloxy)-6-methyl-4-pyrimidinyl]-2-[5-(4-methyl-1-piperazinyl)methyl-2-pyrazinyl]amino-1,3-thiazole; anticarcinogenic agent; G1 phase in cell cycle; great selectivity
04/03/2008US20080081810 rac-6-chloro-3-(3-chloro-benzyl)-3-(3-isopropoxy-phenylamino)-1,3-dihydro-indol-2-one; murine double minute (MDM2 ) oncogene inhibitor; feedback control loop of p53 mutant cells; inhibit the interaction between p53 and MDM2 proteins
04/03/2008US20080081809 Novel Compounds
04/03/2008US20080081802 Thiazolyl-Dihydro-Indazole
04/03/2008CA2664572A1 Substituted piperidinophenyl oxazolidinones
04/03/2008CA2662612A1 3-aza-bicyclo[3.1.0]hexane derivatives
04/03/2008CA2660377A1 Quinolinone derivatives
04/02/2008EP1905769A1 Heterocycle-substituted benzimidazole derivative
04/02/2008EP1905764A1 Substituted 2-Phenyl-benzimidazoles and their use as pharmaceuticals
04/02/2008EP1904490A1 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl]phenyl) pyridine-3- sulphonamide
04/02/2008EP1904489A2 Process for the synthesis of triazoles
04/02/2008EP1904474A1 New pyridine analogues
04/02/2008EP1904465A1 Method of synthesis of imidazole-amino acid derivatives and related compounds
04/02/2008EP1904457A2 Compositions and methods for inhibition of the jak pathway
04/02/2008CN101155807A Compounds having tie2 (tek) inhibitory activity
04/02/2008CN101155806A Oxindole oxazolidinone as antibacterial agent
04/02/2008CN101155805A 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
04/02/2008CN101155800A Pyrazolylaminopyridine derivatives useful as kinase inhibitors
04/02/2008CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
04/02/2008CN101155780A Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
04/02/2008CN100378095C Substituted indoles as alpha-1 agonists
04/02/2008CN100378094C Novel 2-pyridinecarboxamide derivatives
04/02/2008CN100378076C Pyridine carboxamide derivatives and their use as pesticides
04/02/2008CN100378074C 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
04/02/2008CN100377645C Substituted arylpyrazoles as parasiticidal agents
04/01/2008US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
04/01/2008US7351824 Intermediates for oxazolidinone antibacterials; N-[3-Chloro-2-(R)-hydroxypropyl]-3-fluoro-4-morpholinyl aniline
04/01/2008US7351823 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide formed by reacting 4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-morpholin-3-one hydrochloride with 5-chlorothiophene-2-carbonyl chloride
04/01/2008US7351735 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias
04/01/2008US7351728 peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis
04/01/2008US7351726 Serine protease inhibitor; angiogenesis factor; antitumor agents; atherosclerosis; thrombosis; chronic obstructive pulmonary disorders; Alzheimer's disease; anticancer agents; antidiabetic agents; cardiovascular disorders
04/01/2008US7351725 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection